Snapdragon tablets focus on efficiency, long battery life and reliable performance, making them ideal for everyday productivity, entertainment and on-the-go multitasking without constant charging ...

The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky ...

NBC’s coverage of Sunday Night Football is led by coordinating producer Rob Hyland and director Drew Esocoff. SNF has won a ...

Satechi powerful Thunderbolt 5 CubeDock and cable are laumching at CES2026. Powered by Intel’s Thunderbolt 5 technology they ...

We can all agree that the iPad has become an essential cockpit tool, but how you mount it matters just as much as the apps ...

Biotin and zinc have become the go-to supplements for anyone dealing with hair thinning. Walk into any chemist, scroll ...

Xiaomi just launched the REDMI Pad 2 Pro and Pad 2 Pro 5G tablets in India, as it had promised. The tablets have a 12.1-inch ...

Redmi Pad 2 Pro, Pad 2 Pro 5G now official. Xiaomi has expanded its Android tablet lineup with the launch of all new Redmi ...

A tablet featuring eye-care displays, TUV-certified low blue light, and anti-glare matte screens to reduce eye strain can be ...

Community Health Inspectors (CHIs) employed by private firms will be provided government-funded tablets, despite the ...

Global pharmaceutical giant Novo Nordisk (NVO) officially launched Wegovy tablets, the world’s first GLP-1 oral medication for adult weight loss, in the U.S. market on January 5. This move marks a ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.